arginine vasopressin has been researched along with clozapine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Li, L; Schafer, JA | 1 |
Li, L; Schafer, JA; Sun, D | 1 |
Feifel, D; Melendez, G; Priebe, K; Shilling, PD | 1 |
Maruyama, T; Motojima, Y; Nishimura, H; Nishimura, K; Nonaka, Y; Saito, R; Sonoda, S; Ueno, H; Ueta, Y; Yoshimura, M | 1 |
Asok, A; Boyle, LM; Brann, DH; Buss, EW; Kandel, ER; Leroy, F; Meira, T; Park, J; Siegelbaum, SA | 1 |
Baba, K; Conway-Campbell, B; Ikeda, N; Kataoka, M; Lightman, S; Maruyama, T; Miyamoto, T; Mori, M; Nishimura, H; Nishimura, K; Nonaka, Y; Sanada, K; Ueta, Y; Yoshimura, M | 1 |
1 review(s) available for arginine vasopressin and clozapine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for arginine vasopressin and clozapine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct.
Topics: Alkaloids; Animals; Arginine Vasopressin; Benzophenanthridines; Clozapine; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Inhibitors; Epinephrine; Fenoldopam; GTP-Binding Proteins; In Vitro Techniques; Kidney Cortex; Kidney Tubules, Collecting; Kinetics; Male; Naphthalenes; Phenanthridines; Pimozide; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, Dopamine D4; Spiperone; Time Factors; Yohimbine | 1998 |
The collecting duct, dopamine and vasopressin-dependent hypertension.
Topics: Animals; Arginine Vasopressin; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Fenoldopam; Hypertension; In Vitro Techniques; Kidney Tubules, Collecting; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; RNA, Messenger; Vasopressins | 2000 |
The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Arginine Vasopressin; Clozapine; Deamino Arginine Vasopressin; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Habituation, Psychophysiologic; Haloperidol; Neural Inhibition; Neurotensin; Rats; Rats, Brattleboro; Rats, Long-Evans; Rats, Mutant Strains; Reflex, Startle; Risperidone; Schizophrenia; Statistics, Nonparametric | 2007 |
Activation of endogenous arginine vasopressin neurons inhibit food intake: by using a novel transgenic rat line with DREADDs system.
Topics: Animals; Arginine Vasopressin; Clozapine; Designer Drugs; Drinking; Eating; Fluorescence; Humans; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats, Transgenic; Rats, Wistar; Receptor, Muscarinic M3; Suprachiasmatic Nucleus; Urine | 2017 |
A circuit from hippocampal CA2 to lateral septum disinhibits social aggression.
Topics: Aggression; Animals; Arginine Vasopressin; CA2 Region, Hippocampal; Clozapine; Excitatory Postsynaptic Potentials; Female; Male; Memory; Mice; Mice, Inbred BALB C; Motivation; Neural Inhibition; Neural Pathways; Presynaptic Terminals; Proto-Oncogene Proteins c-fos; Pyramidal Cells; Receptors, Vasopressin; Septal Nuclei; Social Behavior; Synaptic Transmission; Ventromedial Hypothalamic Nucleus | 2018 |
Chemogenetic activation of endogenous arginine vasopressin exerts anorexigenic effects via central nesfatin-1/NucB2 pathway.
Topics: Animals; Appetite; Appetite Depressants; Arginine Vasopressin; Clozapine; Drinking; Eating; Male; Nucleobindins; Rats, Transgenic; Signal Transduction | 2021 |